Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1808 1
1813 1
1819 1
1821 1
1823 1
1833 1
1838 1
1894 1
1906 1
1908 1
1910 2
1913 1
1914 1
1915 1
1917 2
1924 1
1931 2
1933 1
1944 1
1945 1
1946 5
1947 1
1948 4
1949 2
1951 2
1952 3
1953 3
1954 5
1955 7
1956 9
1957 5
1958 7
1959 3
1960 3
1961 2
1962 7
1963 2
1964 15
1965 17
1966 11
1967 16
1968 15
1969 16
1970 11
1971 10
1972 22
1973 22
1974 14
1975 22
1976 18
1977 21
1978 23
1979 22
1980 20
1981 31
1982 36
1983 28
1984 38
1985 15
1986 24
1987 39
1988 39
1989 33
1990 41
1991 51
1992 52
1993 52
1994 53
1995 44
1996 54
1997 56
1998 59
1999 62
2000 59
2001 54
2002 41
2003 63
2004 63
2005 81
2006 77
2007 66
2008 92
2009 61
2010 91
2011 120
2012 98
2013 126
2014 130
2015 156
2016 153
2017 164
2018 162
2019 167
2020 182
2021 189
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

3,322 results
Results by year
Filters applied: . Clear all
Page 1
Wearables and the medical revolution.
Dunn J, Runge R, Snyder M. Dunn J, et al. Per Med. 2018 Sep;15(5):429-448. doi: 10.2217/pme-2018-0044. Epub 2018 Sep 27. Per Med. 2018. PMID: 30259801 Free article. Review.
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, Levine M. Young AM, et al. Among authors: dunn ja. J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746227 Clinical Trial.
A longitudinal big data approach for precision health.
Schüssler-Fiorenza Rose SM, Contrepois K, Moneghetti KJ, Zhou W, Mishra T, Mataraso S, Dagan-Rosenfeld O, Ganz AB, Dunn J, Hornburg D, Rego S, Perelman D, Ahadi S, Sailani MR, Zhou Y, Leopold SR, Chen J, Ashland M, Christle JW, Avina M, Limcaoco P, Ruiz C, Tan M, Butte AJ, Weinstock GM, Slavich GM, Sodergren E, McLaughlin TL, Haddad F, Snyder MP. Schüssler-Fiorenza Rose SM, et al. Among authors: dunn j. Nat Med. 2019 May;25(5):792-804. doi: 10.1038/s41591-019-0414-6. Epub 2019 May 8. Nat Med. 2019. PMID: 31068711 Free PMC article.
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.
Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF. Paller A, et al. Among authors: dunn jd. Am J Clin Dermatol. 2018 Dec;19(6):821-838. doi: 10.1007/s40257-018-0383-4. Am J Clin Dermatol. 2018. PMID: 30168085 Review.
Longitudinal multi-omics of host-microbe dynamics in prediabetes.
Zhou W, Sailani MR, Contrepois K, Zhou Y, Ahadi S, Leopold SR, Zhang MJ, Rao V, Avina M, Mishra T, Johnson J, Lee-McMullen B, Chen S, Metwally AA, Tran TDB, Nguyen H, Zhou X, Albright B, Hong BY, Petersen L, Bautista E, Hanson B, Chen L, Spakowicz D, Bahmani A, Salins D, Leopold B, Ashland M, Dagan-Rosenfeld O, Rego S, Limcaoco P, Colbert E, Allister C, Perelman D, Craig C, Wei E, Chaib H, Hornburg D, Dunn J, Liang L, Rose SMS, Kukurba K, Piening B, Rost H, Tse D, McLaughlin T, Sodergren E, Weinstock GM, Snyder M. Zhou W, et al. Among authors: dunn j. Nature. 2019 May;569(7758):663-671. doi: 10.1038/s41586-019-1236-x. Epub 2019 May 29. Nature. 2019. PMID: 31142858 Free PMC article.
High-frequency actionable pathogenic exome variants in an average-risk cohort.
Rego S, Dagan-Rosenfeld O, Zhou W, Sailani MR, Limcaoco P, Colbert E, Avina M, Wheeler J, Craig C, Salins D, Röst HL, Dunn J, McLaughlin T, Steinmetz LM, Bernstein JA, Snyder MP. Rego S, et al. Among authors: dunn j. Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):a003178. doi: 10.1101/mcs.a003178. Print 2018 Dec. Cold Spring Harb Mol Case Stud. 2018. PMID: 30487145 Free PMC article.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators. Earl HM, et al. Among authors: dunn ja. Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178152 Free PMC article. Clinical Trial.
Re-imagining Psycho-oncology.
Chambers SK, Dunn J. Chambers SK, et al. Among authors: dunn j. Eur J Cancer Care (Engl). 2019 Jul;28(4):e13136. doi: 10.1111/ecc.13136. Eur J Cancer Care (Engl). 2019. PMID: 31318133 No abstract available.
Peptic ulcer disease.
Sverdén E, Agréus L, Dunn JM, Lagergren J. Sverdén E, et al. Among authors: dunn jm. BMJ. 2019 Oct 2;367:l5495. doi: 10.1136/bmj.l5495. BMJ. 2019. PMID: 31578179 Review. No abstract available.
3,322 results